Trial results

$IMCR — KIMMTRAK (tebentafusp)

Immunocore Holdings plc (IMCR) KIMMTRAK (tebentafusp): trial results in Previously treated advanced melanoma, 2026.

Research by Catalyst Intel

The catalyst

"The Company expects to be able to share topline data as early as the end of 2026."

— Immunocore Holdings plc, 8-K filed 2026-09-14 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

IMCR-KIMMTRAKTEBE-2026

Company

Immunocore Holdings plc

Kind

Trial results

Indication

Previously treated advanced melanoma

Window

2026-01-01 – 2026-12-31

Status

slate

The bar

No bar has been published for this event yet.

Verdicts

Sealed with the bar. Any verdict for this event reaches this page on 2027-01-30; subscribers get it on the day.